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A B S T R A C T
The aim of this paper was to evaluate the ocular findings in patients with chronic renal failure (CRF) undergoing
haemodialysis (HD). In 64 patients undergoing haemodialysis (30 female and 34 male), aged 24–83 years (mean 58
years) on haemodialysis 1–213 months (mean 47 months) complete ocular examination were performed: visual acuity
(VA), intraocular pressure (IOP), biomicroscopic examination and fundoscopy. On right eye sixty-nine percent of pat-
ents had VA 0.6 or better, and on left eye 84% of patients had VA 0.6 or better. Mean IOP before dialysis was 15 mmHg
and after dialysis was 14 mmHg. In 9 patients (14%) we found corneo-conjunctival calcium deposits. No correlation of
ocular calcification and parathyroid hormone (PTH) level or calcium and phosphate product were observed. 39 (60%)
patients had cataract. Hypertensive vascular changes were seen in 44 (68%) patients and in 6 (7%) patients age-related
macular degeneration. Seven patients had diabetes mellitus and in 5 diabetic retinopathy was observed. Patients with
CRF or who are receiving HD represent unique group of patients. Pathologic change could be found in many tissue and
organs, therefore we suggest ocular examination more frequently in dialysis patients.
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Introduction
Chronic renal failure (CRF) is an irreversible deteri-
oration of renal function. It is characterised by a numer-
ous disorders that involve many organs: bone, heart and
blood vessels, periferal nerves etc. In dialysis patients
some disorders could be consequence of the dialysis
treatment per se. The most common cause of CRF is dia-
betic nephropathy, followed by hypertensive nephroan-
giosclerosis and various primary and secondary glome-
rulonephropaties. Pathologic changes of many organs
could be also the consequences of these diseases. One of
the most important complication of chronic renal failure
is disturbance of mineral metabolism, i.e. secondary
hyperparathyroidism. Common feature of mineral me-
tabolisam disturbance in CRF is soft tissue calcification.
The pathogenesis of this calcification is not completely
understood but ocular calcifications are among the most
frequently observed. The visual sistem could be ad-
versely affected not only by pathologic calcification than
also by by other disturbance in CRF and haemodialysisi
per se. Therefore the goal of our study was to evaluate
the ocular changes in chronic haemodialysis patients.
Glaucoma is one of most important cause of blind-
ness worldwide is impotrant to observe IOP in dialysis
patients especialy in patients with glaucoma. Changes
in haemoconcentration, plasma colloid-osmotic pressu-
re, plasma osmolarity during HD could be registrated. It
is important to reveal their influence on IOP. Posterior
eye segment pathology, according to main causes of
CRF, could be hypertensive vascular changes and dia-
betic retinopathy1–15.
Patients and Methods
In our study we included 64 patients, 30 females and
34 males. Mean age of patients was 58 years (range,
24–83 years). Duration of HD ranged from 1 to 213
months (mean 47 months). All patients were on haemo-
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dialysis 3 times a week, 4 hours; bicarbonate dialysate
was used with 1.5 mmol/l Ca concentration. Most of the
patients were on calcitriol therapy (up to 0.5 g per day)
and calcium carbonate was used as phosphate binder
(up to 4 g per day). Heparin was used during haemo-
dialysis in all patients in a dose up to 4000 i.u. In all pa-
tients we performed ocular examination which include
visual acuity (VA), intraocular pressure (IOP), biomicro-
scopic examination, fundoscopy. Visual acuity was as-
sessed with Snellen chart. We measured IOP using
Goldmann aplanation tonometry half an hour before
and half an hour after HD treatment. On slit lamp we
examined corneal and conjuctival calcium deposits. We
used Porter and Crombie¹ method for gradation of cal-
cium deposits. Transparency of lens was observed on slit
lamp and classified according to the lens opacities clas-
sification system III (LOCS III)16 For ocular background
we used direct and indirect fundoscopy and fundus pho-
tography. Intact parathyroid hormone (PTH) level (nor-
mal range 1–64 g/l), and calcium (Ca) (normal range
2.25–2.6 mmol/L) phosphorus (P) (normal range 0.64–
1.35 mmol/L) level were detected and and calcium and
phosphorus product calculated. The aim was to find cor-
relation between the amount of calcium deposits on cor-
nea and conjunctiva and serum levels of PTH, Ca, P, and
Ca x P product.
Results
Sixty-nine percent of patients had visual acuity 0.6
or better on right eye. On left eye 84% patients had VA
0.6 or better. In our group we did not have patients with
glaucoma. IOP before treatment ranged 11–20 mmHg
(mean 15 mmHg) and 11–20 mmHg (mean 14 mmHg)
after the treatment so we did not find significant chan-
ges IOP during HD, but we had mild decrease in IOP
(Table 1). One patient (F) developed acute elevation of
IOP on left eye, 41 mmHg 7 months after beginning of
HD.
In 9 (14%) patients we found corneo-conjuctival de-
posits. They were mostly located in superficial subepi-
thelial part of corneal limbal area as well in paralimbal
nasal and temporal part of conjunctiva in horizontal me-
ridian from 9 to 3 o´clock According to Porter and
Crombie classification they were mostly mild to moder-
ate (Table 2). We did not find significant corneal edema.
Central parts of the cornea was clear. In five patients
with calcium deposits we also found higher value of se-
rum PTH. Sixteen patients had higher values of serum
PTH but without calcium deposits (Table 3).
When we calculated the product of serum calcium
and phosphorus, we found that forty-five patients had
high level of Ca x P but no deposits. Nine patients had
corneo-conjuctival calcium deposits and high level in Ca
x P (Table 4). We did not find statistically significant
correlation between calcium deposits and level of PTH,
nor calcium deposits and value of Ca x P using Kruskal-
Wallis test.
Thirty-nine patients had cataracts. In twenty-nine
patients (45%) we found initial form and in 10 (15%) pa-
tients we found advance form of cataracts according to
LOCS III classification (Table 5). On posterior eye seg-
ment we found hypertensive vascular changes in 44
(68%) patients. Most patients had mild to moderate hy-
pertensive vascular changes. Six patients had advanced
vascular sclerosis (Table 6). At the Department for hae-
modialysis were 7 patients with diabetes mellitus which
is also a important cause for HD. We found nonproliphe-
rative diabetic retinopathy in 4 (6%) patients, proliphe-
rative diabetic retinopathy in 1 (1.5) patients. Three
(4%) patients were treated by argon laser photocoagu-
lation (Table 7). In 6 (7%) patients we found aged-re-
lated macular degeneration (ARMD).
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TABLE 1
IOP BEFORE AND AFTER DIALYSIS
Before dialysis After dialysis
Range 11–20 mmHg 11–20 mmHg
Mean 15 mmHg 14 mmHg
TABLE 2
GRADING CALCIUM DEPOSITS (GRADE 0–5)
Grade 0 1 2 3 4 5
Patients 55 3 2 3 1 0
TABLE 3
CALCIUM DEPOSITS AND VALUE OF PTH
Ca deposits Total MV SD
With 5 342.6 278.0
Without 16 342.7 327.0
TABLE 4
CALCIUM DEPOSITS AND VALUE OF CA x P
Ca deposits Total MV SD
with 9 4.3 0.9




29 (45%) 10 (15%)
TABLE 6
HYPERTENSIVE VASCULAR CHANGES SCHEI
I II III IV
18 (28%) 20 (31%) 5 (7%) 1 (1%)
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Discussion
Patients with end stage renal disease (ESRD) under-
going haemodialysis represent specific group of patients
who have more than one disease and therefore should be
carefully examined. About 80% of patients had visual
acuity 0.6 and better. In our study we had two patients
who were blind to one eye due to traumatic injury. Soft
tissue calcifications are often seen in CRF patients,
moreover due to increasing age and longevity of haemo-
dialysis and better sophisticated diagnostic techniques,
pathologic extraskeletal calcifications could be find in
every haemodialysis patients. The pathogenesis is not
completely understood. It was thought that it represent
dystrophic, passive calcification due to physical-chemi-
cal processes. But today we know that is is also a regu-
lated process modulated by various genes and proteins,
i.e. osteocalcin, osteoponitn etc. Ocular calcifications
(corneal nad conjunctival) are the most comon meta-
static calcification in patients with CRF and on HD. Pa-
tients with corneal calcifications could complain of a
gritty sensation and in patients with conjuctival calcifi-
cations acute injction and inflammation of conjuctiva
(»red eye syndrome) could be find. Calcium deposits
mainly consist calcium phosphat salts. There are some
specific reasons in pathogenesis of ocular calcifications
is not fully understood. Some authors suggests that cal-
cium deposits are more likely to perciptate at cornea
and conjuctiva due to loss of CO2 from that tissue with
rise in pH which is ideal for precipitation of calcium
phosphat salts in the presence of high values of serum
calcium phosphat.1,2 It is also possible that some kind of
corneal degeneration or minor corneal and conjuctival
trauma have significant role in deposit formation. Vu-
nerability can be result of decrease of tear secretion dur-
ing each haemodialysis treatment5–8. We find 9 patients
with corneo-conjuctival deposits which are grade 1–4
and duration of HD in this patients were between 2–12
years (mean 7 years). No correlation of PTH level or Ca
x P product level were found. It is in agreement with
well known fact that pathologic calcifications is not only
due to increased level of calcium and phosphorus (i. e.
passive process). It is active process yet not completly
understood.
In our study we found no significant implication on
visual acuity in patients with corneo-conjuctival depos-
its because the deposits were mild to moderate. De-
posits are placed in limbal area and only in later can
have implication on visual acuity. In three patients who
complained of itching we revealed minute corneal and
conjunctival erosions after staining with fluorescein
dye. There were no significant changes in IOP, only with
slight decrease in IOP during HD. One patient, 74 year
old woman, has developed acute rise in IOP after 7
months on dialysis and she was admitted to our clinic.
Before that elevation we measured IOP three times on
our clinic during 7 months and values were between
11–13 mmHg for both eyes. She received medical ther-
apy for month and IOP values were between 9–15
mmHg. After that she was without therapy with values
of IOP between 11–16 mmHg. Exact mechanism of
changes of IOP during HD is not fully understood, so we
assumed that elevation of IOP during haemodialysis is
multifactoriel11–13,15. Patients with lower values of IOP
could develop acute elevation in IOP. Some studies dem-
onstrated decrease in IOP during HD. Changes in plas-
ma colloid-osmotic pressure could be responsible for
intradialytic decrease in IOP. Colloid-osmotic pressure
is higher during HD due to decrease in plasma volume
owning to removal of water from plasma. To correct this
imbalance water from interstitial spaces and also aque-
ous humor move to plasma. So we had decrease in
IOP14. Important role as well is production and outflow
of aqueous humor. In eyes with impair aqueous outflow
and shallow anterior chamber we could observe increase
in IOP. For intradialytic increase in IOP could be re-
sponsible post dialitytic urea rebound (PDUR)17. Find-
ings on ocular background are correspondent with main
cause for HD. Forty-four patients have hypertensive
vascular changes. Seven patients have diabetes and all
have diabetic retinopathy. ARMD we found in 6 patients
and they are from older group of patients. Ocular back-
ground examination is very important in these patients
because we can reveal early changes on retinal vessels
which can also helps in systemic evaluation of disease,
efficiency of treatment, compliance with medication and
progression of disease18–21.
In conclusion, we suggest ocular examination for all
patients with CRF especially before starting with HD
treatment. It is necessary to prevent any ocular pathol-
ogy in dialytic patients because every deterioration in
visual system can have great implication in everyday
life and social ability of dialytic patients. Patients un-
dergoing HD are very complex we suggest multidisci-
plinary approach to patients on haemodialysis





Nonprolipherative diabetic retinopathy 4 (6%)
Prolipherative diabetic retinopathy 1 (1.5%)
Argon laser photocoagulation 3 (3%)
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O^NE PROMJENE KOD BOLESNIKA S KRONI^NIM ZATAJENJEM BUBREGA NA HEMODIJALIZI
S A @ E T A K
Cilj ovoga rada je evaluacija o~nih promjena kod bolesnika s kroni~nim zatajenjem bubrega na hemodijalizi. Kod
64 bolesnika (30 `ena i 34 mu{karca) s kroni~nim zatajenjem bubrega u~injen je o~ni pregled: vidna o{trina, intra-
okularni tlak (IOT), biomikroskopski pregled, fundoskopija. Vidna o{trina na desno oko kod 69% bolesnika je bila 0.6
i bolja, dok na lijevo oko 84% bolesnika imalo vidnu o{trinu 0.6 i bolju. Srednja vrijednost pola sata prije dijalize bila
je 15 mmHg, a pola sata nakon dijalize 14 mmHg. Kod 9 (14%) bolesnika na{li smo korneo-konjuktivalne depozite.
Nije na|ena povezanost izme|u prisutnosti kalcifikata na ro`nici i spojnici te vrijednosti paratiroidnog hormona
(PTH) i umno{ka vrijednosti kalcija i fosfora. Kod 60% bolenika na|ena je katarakta. Na o~noj pozadini na|ene su u
44 bolesnika hipertenzivne promjene i u 6 bolesnika senilna makularna degeneracija. Sedam bolesnika je imalo dija-
betes, a kod 5 je na|ena dijabeti~ka retinopatija. Bolesnici s kroni~nim zatajenjem bubrega na hemodijalizi ~ine
posebnu skupinu bolesnika. Patolo{ke promjene nalazimo na mnogim tkivima i organima, stoga savjetujemo o~ni
pregled kod dijaliti~nih bolesnika u kra}im vremenskim razmacima.
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